Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Xoma Corp 8.625% (XOMAP)

Xoma Corp 8.625% (XOMAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 4,758 K
  • Annual Income, $ -40,831 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.46 +1.73%
on 12/13/24
25.98 -0.31%
on 11/26/24
+0.17 (+0.66%)
since 11/22/24
3-Month
25.45 +1.76%
on 10/08/24
26.51 -2.30%
on 10/24/24
+0.26 (+1.02%)
since 09/23/24
52-Week
24.61 +5.24%
on 04/02/24
26.51 -2.30%
on 10/24/24
+0.40 (+1.57%)
since 12/22/23

Most Recent Stories

More News
XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events

Added six assets to its portfolio of potential milestone and royalty assets in 2021

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events

XOMA’s portfolio of potential milestone and royalty assets now has greater than 70 drug candidates. Company ended the first quarter of 2021 with $67.8 million in cash.  The April 2021 $40 million...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMA Announces Approval of First Preferred Stock Dividend

EMERYVILLE, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors approved a dividend of $0.71875 per share...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar